A case of relapsed pan-colonic ulcerative colitis accompanied with gastroduodenal lesions immediately after COVID-19
Some patients with ulcerative colitis (UC) suffer from complicated UC-associated upper gastrointestinal lesions. However, the trigger of these lesions has not been clarified. Herein, we present a 28-year-old man with relapsed pan-colonic UC accompanied by gastroduodenal lesions immediately after contracting coronavirus disease 2019 (COVID-19). In this patient, UC relapsed approximately 7 days after the COVID-19 onset, despite being in remission for 3 years. The patient also developed symptoms such as epigastric pain and nausea on day 19 of COVID-19. The endoscopic and pathologic findings of the stomach and duodenum closely resembled colorectal lesions of UC; accordingly, we diagnosed the patient with UC-associated gastroduodenal lesions. Corticosteroids were significantly effective in the colorectal and upper gastrointestinal lesions, leading to remission. This report is the first to describe UC-associated upper GI lesions that developed right after COVID-19 infection. Therefore, COVID-19 can be a possible trigger of UC-associated upper gastrointestinal lesion. Further studies are needed to understand the relationship between the onset of UC or UC-associated upper GI lesions and COVID-19.
Authors
- Morihisa Hirota (ORCID: https://orcid.org/0000-0001-5682-0911)
- Takayuki Kogure (ORCID: https://orcid.org/0000-0002-7449-0079)
- Kennichi Satoh (ORCID: https://orcid.org/0000-0003-1324-6387)
- Yoko Kawakami
- Tomonori Satoh
- Katsuya Endo (ORCID: https://orcid.org/0000-0002-6449-8392)
- Daisuke Fukushi (ORCID: https://orcid.org/0000-0001-5912-3695)
- Yuki Yoshino (ORCID: https://orcid.org/0000-0001-8077-0301)
- Atsuko Takasu
- Shiho Kondo
Institutions
- Tohoku Medical and Pharmaceutical University Hospital (JP)
Publication Details
- Journal
- Clinical Journal of Gastroenterology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1007/s12328-025-02107-0
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63
Funders
- Tohoku Medical and Pharmaceutical University